HPV vaccine reduces infection, even in unvaccinated

July 9, 2012, Cincinnati Children's Hospital Medical Center

The HPV vaccine not only has resulted in a decrease in human papillomavirus infection in immunized teens but also in teens who were not immunized.

The study is believed to be the first to show a substantial decrease in HPV infection in a community setting as well as herd protection – a decrease in infection rates among unimmunized individuals that occurs when a critical mass of people in a community is immunized against a contagious disease.

The Cincinnati Children's Hospital Medical Center study will be published online July 9 in the eFirst pages of Pediatrics.

"Infection with the types of HPV targeted by the decreased in vaccinated by 69 percent," says Jessica Kahn, MD, MPH, a physician in the division of Adolescent Medicine at Cincinnati Children's and lead author of the study. "Two of these HPV types, HPV-16 and HPV-18, cause about 70 percent of cervical cancer. Thus, the results are promising in that they suggest that vaccine introduction could substantially reduce rates of cervical cancer in this community in the future."

The first HPV vaccine was licensed for use in the United States in June 2006. The U.S. Advisory Committee on Immunization Practices has recommended vaccination of girls and women between the ages of 11 and 26 to reduce rates of HPV infection, which ultimately can lead to cervical cancer.

In 2006 and 2007, Dr. Kahn and colleagues at Cincinnati Children's recruited 368 young women between the ages of 13 and 16 from two primary care clinics in the city of Cincinnati. The young women had sexual contact but none were vaccinated. In 2009 and 2010, they recruited a different group of 409 young women in the same age range, more than half of whom had received at least one dose of the vaccine. The researchers compared pre- and post-vaccination HPV prevalence rates.

The prevalence of vaccine-type HPV decreased 58 percent overall, from 31.7 percent to 13.4 percent. The decrease was high among vaccinated participants (69 percent), but also was substantial for those who were unvaccinated (49 percent).

Dr. Kahn says the decrease in vaccine-type HPV among vaccinated participants was "especially remarkable," given that participants were sexually experienced, many were exposed to vaccination-type HPV before vaccination, and only one dose of the vaccine was required to be considered vaccinated.

Dr. Kahn emphasizes that despite the evidence of herd immunity demonstrated in her study, vaccination of all young women between the ages of 11 and 26 is important to maximize the health benefits of vaccination.

Although vaccine-type HPV decreased, the overall prevalence of HPV (including types not targeted by the vaccine) in the study was "extremely high," says Dr. Kahn. "Nearly one in four unvaccinated study participants was already positive for at least one high-risk HPV type."

Most participants in the study were young, black women, many with Medicaid insurance. Given this, and the fact that the study was a relatively small one conducted in a single city, larger studies with more representative samples are needed to definitively determine the public health impact of the , says Dr. Kahn.

Explore further: Lack of clarity about HPV vaccine and the need for cervical cancer screening

Related Stories

Lack of clarity about HPV vaccine and the need for cervical cancer screening

July 7, 2011
The research will be presented today at the Annual Scientific Meeting of the Society of Academic Primary Care, hosted this year by the Academic Unit of Primary Health Care, University of Bristol.

Study shows girls believe HPV vaccine protects from other STDs

January 6, 2012
(Medical Xpress) -- A new study published in the Archives of Pediatric and Adolescent Medicine shows that almost a quarter of girls surveyed believe that the HPV vaccine will also help prevent other STDs. This new information ...

Cervical disease sufferers could benefit from HPV vaccine

March 28, 2012
Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease, a study published today in the British Medical Journal ...

Recommended for you

Infant growth patterns affected by type of protein consumed

May 14, 2018
A new study by CU School of Medicine researchers has determined that choices of protein intake from solid foods has a significant impact on infant growth during the first year of life.

Parents say intense gun violence in PG-13 movies appropriate for teens 15 and older

May 14, 2018
Parents are more willing to let their children see PG-13 movies with intense gun violence when the violence appears to be "justified," used in defense of a loved one or for self-protection, than when it has no socially redeeming ...

Study finds prenatal marijuana use can affect infant size, behavior

May 10, 2018
Smoking during pregnancy has well-documented negative effects on birth weight in infants and is linked to several childhood health problems. Now, researchers at the University at Buffalo Research Institute on Addictions have ...

Very-low-carb diet shows promise in type 1 diabetes

May 7, 2018
Very-low-carbohydrate diets can improve blood sugar control in type 1 diabetes, with low rates of hypoglycemia and other complications, according to an online patient survey. The researchers, led by Belinda Lennerz, MD, PhD, ...

Many teens switch from hi-cal sodas to hi-cal sports drinks

May 7, 2018
(HealthDay)—Teens who were once hooked on sugary sodas may now be now turning to sugary sports drinks, a new study reveals.

SWAT team of immune cells found in mother's milk

May 3, 2018
Immune cells that are ready to take action against invaders like bacteria have been found in women's breast milk, researchers say.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.